Emerging technologies for point-of-care genetic testing.

Can We Apply the Control Material from Standard Clinical Chemistry Analyzer for Usage in the Point of Care Testing Analyzer?

How Much Can We Save the Cost from Shifting from Single - Test Strip to Multiple - Test Strip in Point of Care Testing Analysis for Common Clinical Chemistry Parameters ?

ANZHSN Bulletin Issue 6.pub

documents a continuing activity by HealthPACT in Horizon Scanning for Health Technology. At the February meeting 25 emerging technologies were discussed and considered and the newsletter covers a selection of these including point of care testing for influenza, renal transplantation using incompatible blood group donors and a number of other interesting and emerging technologies. A number of in...

Improving healthcare accessibility through point-of-care technologies.

BACKGROUND The NIH is committed to improving healthcare quality in the US and has set up initiatives to address problems such as the fragmented nature of healthcare provision. A hypothesis has been developed that testing closer to the point at which care is delivered may reduce fragmentation of care and improve outcomes. METHODS The National Institute of Biomedical Imaging and Bioengineering ...

I-36: Preimplantation Genetic Diagnosis - Where Have We Been and Where Are We Going

Preimplantation genetic diagnosis (PGD) is now considered routine in IVF laboratories with micromanipulation capability and access to genetic diagnostic services. The past two decades have witnessed a dramatic increase in the use of PGD, the number of cycles performed, and the indications for which PGD has been used. This increase has been mirrored by a slow, but steady, increase in the range o...